United States · FDA National Drug Code directory
GAVILAX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 17856-0310_536f279a-56fc-0a05-e063-6294a90a2528
- Product NDC
- 17856-0310
- Form
- POWDER, FOR SOLUTION
- Composition / generic term
- Polyethylene Glycol 3350
- Labeler
- Atlantic Biologicals Corp.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20091009
- Source listing expiry
- 20271231
Source-listed ingredients
- POLYETHYLENE GLYCOL 3350 — 17 g/17g
These values do not establish equivalence or a dose recommendation.
Packages
- 50 CUP, UNIT-DOSE in 1 CASE (17856-0310-1) / 2 g in 1 CUP, UNIT-DOSE · 17856-0310-1
- 72 POUCH in 1 CASE (17856-0310-2) / 2 g in 1 POUCH · 17856-0310-2
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →